Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study

Detalles Bibliográficos
Autores principales: Iwasa, Satoru, Wang, Zi‐Xian, Muro, Kei, Morita, Satoshi, Park, Young Suk, Zhang, Dongsheng, Yamada, Yasuhide, Sakamoto, Junichi, Kim, Tae Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091100/
https://www.ncbi.nlm.nih.gov/pubmed/36647206
http://dx.doi.org/10.1002/cac2.12406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091100/
https://www.ncbi.nlm.nih.gov/pubmed/36647206
http://dx.doi.org/10.1002/cac2.12406

Ejemplares similares